Tru-D Smart UVC

Tru-D SmartUVC Protects Patients from Hospital-Acquired Infections

Tru-D is one way Jackson Hospital is raising the bar when it comes to the level of care it provides to all patients. According to the CDC, in the U.S., one in 25 patients acquire an HAI while being treated, and 75,000 patients die during their hospitalizations each year.

Tru-D, which works by generating UV light energy that modifies the DNA or RNA structure of an infectious cell, is the only portable UV disinfection system on the market with Sensor360™ technology. The device’s patented technology calculates the amount of UVC energy needed to disinfect an entire room while taking into account room variables – such as size, shape, surface reflectivity and the amount and location of equipment in the room – and delivers a lethal dose from a single location, effectively eliminating lingering pathogens in the space. Tru-D kills deadly germs such as Ebola, methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile (C. diff), Middle East Respiratory Syndrome (MERS), Norovirus and Enterovirus D68.

After a hospital staff member cleans the room using traditional methods, Tru-D is rolled in the room to complete the process. The robot is remotely-operated and features iTru-D, an application that tracks infection control data and simultaneously uploads the information to the hospital’s web portal. Set up is quick and easy and does not require input of room measurements or covering of windows and vents. The system can disinfect an entire room from one location, eliminating the need to move it to multiple places in the room. Its patented Sensor360™ technology analyzes the unique variables of the room and floods the space with the proper, lethal dose of UV light energy. Tru-D spends whatever time is necessary to confidently eliminate infectious germs from contaminated surfaces before shutting down and notifying the operator that disinfection is complete.

About Tru-D

Tru-D SmartUVC is the only UV disinfection device backed by a CDC-funded, randomized clinical trial to show that it is capable of reducing the transmission of health care-associated infections by up to 30 percent. More Tru-Ds have been deployed to disinfect hospitals across the globe than all other competing look-alike offerings, fighting deadly pathogens such as C. diff, MRSA, CRE, VRE, MERS, Ebola and many more. An effective and innovative technology.

Visit tru-d.com for more information.